Security key
04351P101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 47,871,754
- Total 13F value
- $5,391,239,456
- Share change
- +1,821,383
- Put/Call ratio
- 30%
- SEC-reported price per share
- $112.61
- Number of holders
- 143
- Value change
- +$191,350,357
- Number of buys
- 65
- Number of sells
- 80
- Shares outstanding
- 62,915,156
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
143
Top holders
10
ASND full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04351P101
Recent filing periods:
Ownership snapshot
Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
12%
FMR LLC
7.6%
RA CAPITAL MANAGEMENT, L.P.
6.7%
BAKER BROS. ADVISORS LP
5.4%
ORBIMED ADVISORS LLC
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
12%
|
$1,079,751,000
7,761,296 shares
|
— | 31 Dec 2019 |
| FMR LLC |
13F
Company
|
7.6%
|
$664,152,000
4,773,954 shares
|
— | 31 Dec 2019 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
6.7%
|
$582,265,000
4,185,342 shares
|
— | 31 Dec 2019 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5.4%
|
$471,654,000
3,390,270 shares
|
— | 31 Dec 2019 |
| ORBIMED ADVISORS LLC |
13F
Company
|
5.3%
|
$465,092,000
3,343,100 shares
|
— | 31 Dec 2019 |
| Artisan Partners Limited Partnership |
13F
Company
|
3.4%
|
$299,998,000
2,156,396 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
143
Shares
47,871,754
Rows available
143
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
139
Q1 2020 holders
143
Holder diff
4
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend